Synthetic Peptides Derived from the Variable Regions of an Anti-CD4 Monoclonal Antibody Bind to CD4 and Inhibit HIV-1 Promoter Activation in Virus-infected Cells
Open Access
- 1 February 1999
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (6) , 3789-3796
- https://doi.org/10.1074/jbc.274.6.3789
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytesNature Biotechnology, 1997
- Specific Binding of a Synthetic Peptide Derived from an Antibody Complementarity Determining Region to PhosphatidylserineThe Journal of Biochemistry, 1995
- A synthetic peptide with anti‐platelet activity derived from a CDR of an anti‐GPIIb‐IIIa antibodyFEBS Letters, 1994
- Antibody-structure-based design of pharmacological agentsTrends in Biotechnology, 1994
- Antibody framework residues affecting the conformation of the hypervariable loopsJournal of Molecular Biology, 1992
- Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and applicationsJournal of the American Chemical Society, 1991
- Functional expression of the CD4 protein after cross-linking to red blood cells with a bifunctional reagentBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Crystal structure of an HIV-binding recombinant fragment of human CD4Nature, 1990
- Sequence and linkage of the vχ21a and g germ‐line gene segments in the mouseEuropean Journal of Immunology, 1989
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984